Jp. Moatti et al., Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment, AIDS, 14(2), 2000, pp. 151-155
Objectives: To assess adherence to highly active antiretroviral therapies (
HAART) in a cohort of French patients infected by HIV through injection dru
g use (IDU), and the impact on adherence of buprenorphine ambulatory drug m
aintenance treatment (DMT) which has been widely introduced since 1996.
Design: Adherence assessment at first visit after initiation of HAART in th
e MAN-IF2000 cohort study.
Methods: Patient's face-to-face and self-administered questionnaires. Univa
riate and logistic regression adjusted odds ratios (OR) to compare characte
ristics of nonadherent versus adherent patients.
Results: Of the 164 patients, 34.8% took less than 80% of the prescribed HA
ART doses during the previous week. Decrease in viral load titres after ini
tiation of HAART was significantly lower among non-adherent patients. After
adjustment by logistic regression, non-adherence was associated with young
er age, alcohol consumption, frequency of negative life-events during the p
rior 6 months and active drug use. However, IDU in buprenorphine DMT reache
d higher levels of adherence (78.1%) than ex-IDU (65.5%), although this dif
ference did not reach statistical significance.
Conclusion: Prescription of buprenorphine DMT may increase adherence to HAA
RT among HIV-infected opiate-dependent patients. Reducing the negative impa
ct of stressful life-events through psychosocial interventions should be co
nsidered, even for those who have stopped using drugs. (C) 2000 Lippincott
Williams & Wilkins.